iHuman Inc ADR Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $115.4M-8.7% YoYTTM through 31 Dec 2025
Net Income $13.6M+1.0% YoYTTM through 31 Dec 2025
Free Cash Flow $6.6MTTM through 31 Dec 2025
Margins
| Current | |
|---|---|
| Gross Margin | 67.9% |
| EBITDA Margin | 9.2% |
| Operating Margin | 8.3% |
| Net Margin | 11.8% |
Returns
9.6%ROE
7.0%ROA
-66.0%ROIC
Balance Sheet Health
Debt / Equity0.01x
Current Ratio3.57x
Net Debt-$163Mnet cash position
Cash & Equivalents$164.6M
Quality Metrics
Altman Z-Score2.28
Piotroski F-Score5 / 9
FCF Margin5.8%
Multi-Year Trend
RevenueFY2025: $807M
Diluted EPS$0.05TTMFY2025: $0.36
Dividend
$0.10Per share, FY20266.00%Yield
Capital Allocation
R&D Spend$29.8M
Capex Intensity0.6%
Segment Performance
No segment data available.
Financials converted at 6.9961 from RMB.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.